HYDROXYSTILBAMIDINE ISETHIONATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hydroxystilbamidine Isethionate, and what generic alternatives are available?
Hydroxystilbamidine Isethionate is a drug marketed by Sanofi Aventis Us and is included in one NDA.
The generic ingredient in HYDROXYSTILBAMIDINE ISETHIONATE is hydroxystilbamidine isethionate. Additional details are available on the hydroxystilbamidine isethionate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYDROXYSTILBAMIDINE ISETHIONATE?
- What are the global sales for HYDROXYSTILBAMIDINE ISETHIONATE?
- What is Average Wholesale Price for HYDROXYSTILBAMIDINE ISETHIONATE?
Summary for HYDROXYSTILBAMIDINE ISETHIONATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 11 |
| Patent Applications: | 39 |
| DailyMed Link: | HYDROXYSTILBAMIDINE ISETHIONATE at DailyMed |
US Patents and Regulatory Information for HYDROXYSTILBAMIDINE ISETHIONATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | HYDROXYSTILBAMIDINE ISETHIONATE | hydroxystilbamidine isethionate | INJECTABLE;INJECTION | 009166-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
